SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-17-000033
Filing Date
2017-05-10
Accepted
2017-05-10 17:25:00
Documents
81
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avdl2017q1.htm 10-Q 1213596
2 EXHIBIT 31.1 exhibit311q12017.htm EX-31.1 9903
3 EXHIBIT 31.2 exhibit312q12017.htm EX-31.2 9789
4 EXHIBIT 32.1 exhibit321q12017.htm EX-32.1 5497
5 EXHIBIT 32.2 exhibit322q12017.htm EX-32.2 5500
  Complete submission text file 0001012477-17-000033.txt   6956301

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avdl-20170331.xml EX-101.INS 1710962
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20170331.xsd EX-101.SCH 47883
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20170331_cal.xml EX-101.CAL 104094
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20170331_def.xml EX-101.DEF 158566
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20170331_lab.xml EX-101.LAB 578237
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20170331_pre.xml EX-101.PRE 337912
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 17831628
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences